All hepatitis B articles
-
NewsScientists reveal significant burden of liver cancer attributable to hepatitis B and alcohol globally
A new study analyzes and compares the epidemiological trends of liver cancer attributed to hepatitis B (LCHB) and alcohol use (LCAL) over the past 32 years.
-
NewsMen who have sex with men in Europe still vulnerable to hepatitis A and B
Research analysing European survey data from 113,884 men who have sex with men (MSM) indicates that while most MSM have a basic understanding of viral hepatitis, only 44% report having been vaccinated against both hepatitis A and B.
-
NewsStudy reveals vaccination patterns among LGBTQ+ adults in New Jersey and New York
A new study led by Rutgers Health researchers has uncovered important insights into vaccination patterns among LGBTQ+ adults in New Jersey and New York. The findings shed light on disparities in vaccine uptake within this diverse population.
-
NewsNew technique offers insights into the complexities of chronic Hepatitis B infection
A new technique called spatial transcriptomics is used to gain a deeper understanding of the interplay between chronic hepatitis B (CHB) infection and the immune system within the liver, paving the way for developing novel therapeutic strategies.
-
NewsScientists unveil hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression
In liver cells under oxidative stress, HBV core protein (HBc) perturbs mitochondrial dynamics and prevents cellular recycling of damaged mitochondria, thereby driving liver disease progression, a new study finds.
-
NewsTenofovir alafenamide treatment achieves positive results in Chinese chronic hepatitis B patients
A five-year treatment regime with tenofovir alafenamide achieves high rates of viral suppression, alanine aminotransferase normalization, and favorable bone and renal safety in Chinese chronic hepatitis B patients.
-
NewsPaclitaxel-induced immune dysfunction and activation of transcription factor AP-1 facilitate Hepatitis B virus replication
A study finds that Paclitaxel treatment directly promotes HBV replication and transcription, leading to HBV reactivation in HBV stable expression cell models, HBV natural infection cell models, and HBV transgenic mouse models.
-
NewsChanging relationship between viral replication and the severity of hepatic necroinflammatory damage in patients with chronic hepatitis B virus infection
This study aimed to clarify the relationship between HBV replication and hepatic inflammation during disease progression of chronic hepatitis B virus (HBV) infection.
-
NewsMechanism of action of the hepatitis B and D virus cell entry inhibitor bulevirtide deciphered
An international research team has succeeded in deciphering the molecular structure of bulevirtide in complex with the HBV/HDV receptor NTCP at the molecular level.
-
NewsViruses can cause multiple myeloma cancer, case study finds, offering hope for treatment
An unusual clinical case has led to the discovery that hepatitis B and C viruses are one of the causes of multiple myeloma, and that eliminating infection with antivirals is often the way to fight this type of cancer.
-
NewsStudy reveals how the immune system fights to keep herpes at bay
A recent study, conducted using lab-engineered cells, unveils the precise maneuvers used by host and herpes simplex virus (HSV) in the fight for dominance of the cell.
-
NewsMonoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.
-
NewsWar in Ukraine pushes highly contagious infectious diseases to alarming levels
New research being presented at this year’s ECCMID reveals an extremely worrying picture of rising infectious disease cases and falling levels of childhood vaccination and case detection in Kharkiv, the scene of some of the most intense combat in 2022.
